Case Report
Sarici A, Erkurt MA, Kaya E
Abstract
Primary immune thrombocytopenia (ITP) is an autoimmune disease characterized by isolated thrombocytopenia (<100,000/ µl). In patients newly diagnosed with ITP, treatment is initiated if thrombocyte count is <30,000/µl or if bleeding is present. Corticosteroids are the first treatment option. Second-line treatment is initiated in unresponsive patients and/or in the case of relapse ITP. Splenectomy, rituximab and thrombopoietin receptor agonists are currently make up the most effective second-line treatments. One of the causes of relapse after splenectomy in patients with ITP is the presence of an accessory spleen. Herein, we present a patient who relapsed 3 months after splenectomy and whose accessory spleen was detected 6 years post-splenectomy and at the third abdominal ultrasonography (USG) examination. We aimed to emphasize the importance of insisting on splenic investigation in patients with ITP who have relapsed post-splenectomy